BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Ghiorzo P. Genetic predisposition to pancreatic cancer. World J Gastroenterol 2014; 20(31): 10778-10789 [PMID: 25152581 DOI: 10.3748/wjg.v20.i31.10778]
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10778.htm
(363) (391) (0) (0) (10766) (95)
Number Citing Articles
1
Sarah Graham, Mariia Dmitrieva, Debora Barbosa Vendramini-Costa, Ralph Francescone, Maria A Trujillo, Edna Cukierman, Laura D Wood. From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression. Carcinogenesis 2024; 45(11) doi: 10.1093/carcin/bgae064
2
A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy. 2025;  doi: 10.1002/9781119834090.ch4
3
Bryce A. Seifert, Julianne M. O'Daniel, Krunal Amin, Daniel S. Marchuk, Nirali M. Patel, Joel S. Parker, Alan P. Hoyle, Lisle E. Mose, Andrew Marron, Michele C. Hayward, Christopher Bizon, Kirk C. Wilhelmsen, James P. Evans, H. Shelton Earp, Norman E. Sharpless, D. Neil Hayes, Jonathan S. Berg. Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings. Clinical Cancer Research 2016; 22(16) doi: 10.1158/1078-0432.CCR-16-0015
4
Cade Bennett, Mike Suguitan, John Abad, Akhil Chawla. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines. Pancreatology 2022; 22(6) doi: 10.1016/j.pan.2022.05.005
5
Alexandra R Lewis, Juan W Valle, Mairead G McNamara. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?. World Journal of Gastroenterology 2016; 22(32): 7175-7185 doi: 10.3748/wjg.v22.i32.7175
6
Eileen E. Reynolds, Chyke A. Doubeni, Mandeep S. Sawhney, Zahir Kanjee. Should This Patient Be Screened for Pancreatic Cancer?. Annals of Internal Medicine 2020; 173(11) doi: 10.7326/M20-6384
7
Daniel Netto, Melissa Frizziero, Victoria Foy, Mairéad G. McNamara, Alison Backen, Richard A. Hubner. Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions. Current Oncology 2024; 31(9) doi: 10.3390/curroncol31090385
8
Rakesh Kumar Singh, Awesh K. Yadav, Rima Dada, Prabhakar Tiwari, Amit Kumar, Anjali Yadav, Sawant Akash Gowerdhan, Gajanan Paul, Shivam Kumar Pandey, Shreya Singh, Hardev Singh. Theranostics in Cancer Management. 2026;  doi: 10.1016/B978-0-443-34199-1.00005-3
9
Bruna Dalmasso, Eleonora Allavena, Andrea Gambino, Francesca Barbero, Irene Vanni, Cansu Gorgun, Giuseppe Cittadini, Francesco Spagnolo, Enrica Teresa Tanda, Andrea Boutros, William Bruno, Lorenza Pastorino, Paola Ghiorzo. Age-specific pancreatic cancer risk in Italian CDKN2A families. Digestive and Liver Disease 2026;  doi: 10.1016/j.dld.2026.09.004
10
Kinyas Kartal, Zoe Guan, Rong Tang, Molly Griffin, Yan Wang, Danielle Braun, Alison P. Klein, Kevin S. Hughes. Familial pancreatic cancer: who should be considered for genetic testing?. Irish Journal of Medical Science (1971 -) 2022; 191(2) doi: 10.1007/s11845-021-02572-9
11
Wei Zhan, Celeste A. Shelton, Phil J. Greer, Randall E. Brand, David C. Whitcomb. Germline Variants and Risk for Pancreatic Cancer. Pancreas 2018; 47(8) doi: 10.1097/MPA.0000000000001136
12
A. J. Muñoz, M. de Toro, L. Ortega, C. López, A. Gutiérrez, D. S. Juliao, M. Arregui, N. Lobato, I. Echavarría, I. Márquez-Rodas, M. Martín. Venous thromboembolism incidence in cancer patients with germline BRCA mutations. Clinical and Translational Oncology 2022; 24(1) doi: 10.1007/s12094-021-02678-7
13
Nozomi OKUNO, Kazuo HARA. Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling. Choonpa Igaku 2026;  doi: 10.3179/jjmu.JJMU.R.269
14
Farhadul Islam. Current Cancer Biomarkers. 2023;  doi: 10.2174/9789815079364123010008
15
Sofie Joris, Philippe Giron, Catharina Olsen, Sara Seneca, Alexander Gheldof, Shula Staessens, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Erik Teugels, Jacques De Grève, Frederik J. Hes. Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12442-z
16
Francesco Berloco, Gian Maria Zaccaria, Nicola Altini, Simona Colucci, Vitoantonio Bevilacqua. A multimodal framework for assessing the link between pathomics, transcriptomics, and pancreatic cancer mutations. Computerized Medical Imaging and Graphics 2025; 123 doi: 10.1016/j.compmedimag.2025.102526
17
Tanya Dwarte, Skye McKay, Amber Johns, Katherine Tucker, Allan D. Spigelman, David Williams, Alina Stoita. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Hereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0129-1
18
Arivajiagane Arundhathi, Wen-Han Chuang, Jen-Kun Chen, Shin-E Wang, Yi-Ming Shyr, Jiun-Yu Chen, Wei-Neng Liao, Hsin-Wei Chen, Yi-Min Teng, Chiao-Chih Pai, Chih-Hong Wang. Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. Oncotarget 2016; 7(34) doi: 10.18632/oncotarget.10583
19
Gina Gheorghe, Camelia Cristina Diaconu, Vlad Ionescu, Gabriel Constantinescu, Nicolae Bacalbasa, Simona Bungau, Mihnea-Alexandru Gaman, Madalina Stan-Ilie. Risk Factors for Pancreatic Cancer: Emerging Role of Viral Hepatitis. Journal of Personalized Medicine 2022; 12(1) doi: 10.3390/jpm12010083
20
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh, Anke Reinacher-Schick, Giampaolo Tortora, Hana Algül, Eileen M. O’Reilly, David McGuinness, Karen Y. Cui, Katia Schlienger, Gershon Y. Locker, Hedy L. Kindler. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer . New England Journal of Medicine 2019; 381(4) doi: 10.1056/NEJMoa1903387
21
C. Langner. Hereditäres Magen- und Pankreaskarzinom. Der Pathologe 2017; 38(3) doi: 10.1007/s00292-017-0297-6
22
Nuria Garcia-Carbonero, Weiyao Li, Marticela Cabeza-Morales, Javier Martinez-Useros, Jesus Garcia-Foncillas. New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review. International Journal of Molecular Sciences 2018; 19(9) doi: 10.3390/ijms19092468
23
Mark Steven Miller, Peter Allen, Teresa A. Brentnall, Michael Goggins, Ralph H. Hruban, Gloria M. Petersen, Chinthalapally V. Rao, David C. Whitcomb, Randall E. Brand, Suresh T. Chari, Alison P. Klein, David M. Lubman, Andrew D. Rhim, Diane M. Simeone, Brian M. Wolpin, Asad Umar, Sudhir Srivastava, Vernon E. Steele, Jo Ann S. Rinaudo. Pancreatic Cancer Chemoprevention Translational Workshop. Pancreas 2016; 45(8) doi: 10.1097/MPA.0000000000000705
24
Shria Kumar, David C. Metz, David E. Kaplan, David S. Goldberg. The association of Helicobacter pylori with pancreatic cancer . GastroHep 2020; 2(4) doi: 10.1002/ygh2.398
25
. 2024;  doi: 10.70675/7ae27348z0fc9z4e68z93d5z8d512b07bf10
26
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A. A. Brosens. Surgical and molecular pathology of pancreatic neoplasms. Diagnostic Pathology 2016; 11(1) doi: 10.1186/s13000-016-0497-z
27
Yousef M. Hawsawi, Nouf S. Al‐Numair, Turki M. Sobahy, Areej M. Al‐Ajmi, Raneem M. Al‐Harbi, Mohammed A. Baghdadi, Atif A. Oyouni, Osama M. Alamer. The role of BRCA1/2 in hereditary and familial breast and ovarian cancers. Molecular Genetics & Genomic Medicine 2019; 7(9) doi: 10.1002/mgg3.879
28
Timothy J. Brown, Kim A. Reiss. PARP Inhibitors in Pancreatic Cancer. The Cancer Journal 2021; 27(6) doi: 10.1097/PPO.0000000000000554
29
Uma L. Sreedhar, Steve V. DeSouza, Brittany Park, Maxim S. Petrov. A Systematic Review of Intra-pancreatic Fat Deposition and Pancreatic Carcinogenesis. Journal of Gastrointestinal Surgery 2020; 24(11) doi: 10.1007/s11605-019-04417-4
30
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612633
31
Giulia Peserico, Caterina Stornello, Martina Tessari, Antonio Scapinello, Matteo Curtarello, Mario Gruppo, Ottavia De Simoni, Alberto Fantin. Role of Endoscopic Ultrasound (EUS) in the Era of Precision Medicine for Pancreatic Cancer Through Next-Generation Sequencing Technology. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178444
32
Sarah Schott, Rongxi Yang, Sarah Stöcker, Federico Canzian, Nathalia Giese, Peter Bugert, Frank Bergmann, Oliver Strobel, Thilo Hackert, Christof Sohn, Barbara Burwinkel. HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study. Oncotarget 2017; 8(40) doi: 10.18632/oncotarget.18757
33
Michelle F. Jacobs, Elena M. Stoffel. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial Cancer 2024; 23(3) doi: 10.1007/s10689-024-00372-5
34
Sancy A. Leachman, Olivia M. Lucero, Jone E. Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo. Identification, genetic testing, and management of hereditary melanoma. Cancer and Metastasis Reviews 2017; 36(1) doi: 10.1007/s10555-017-9661-5
35
Inès Debbabi, Sophie Vacher, Cindy Neuzillet, Jérome Cros, Françoise Revillon, Ambre Petitalot, Anthony Turpin, Samantha Antonio, Elodie Girard, Célia Dupain, Maud Kamal, Pascal Hammel, Ivan Bièche, Julien Masliah-Planchon, Sandrine M. Caputo. Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma. Therapeutic Advances in Medical Oncology 2023; 15 doi: 10.1177/17588359221146132
36
. 2022;  doi: 10.70675/f216ab05z34c2z4a92z9ebdzca69010c52d8
37
Ayoola O Ogunleye, Rama Krishna Nimmakayala, Surinder K Batra, Moorthy P Ponnusamy. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression. Stem Cells 2023; 41(5) doi: 10.1093/stmcls/sxad017
38
Rachel Michaelson-Cohen, Rachel Beeri, Eliahu Golomb, Ephrat Levy-Lahad. Molecular Pathology in Clinical Practice. 2016;  doi: 10.1007/978-3-319-19674-9_22
39
Jone E. Sampson, Kelly Jo Hamman. A current picture of genetic counseling for familial pancreatic cancer. Expert Review of Quality of Life in Cancer Care 2016; 1(6) doi: 10.1080/23809000.2016.1255552
40
Xin Hu, Zhiyi Xie, Xin Zan, Lu Ma, Hao Li, Chao You, Yan Jiang. Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis. World Neurosurgery 2018; 118 doi: 10.1016/j.wneu.2018.07.019
41
Mark B. Ulanja, Alastair E. Moody, Bryce D. Beutler, Daniel Antwi-Amoabeng, Ganiyu A. Rahman, Olatunji B. Alese. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. Oncotarget 2022; 13(1) doi: 10.18632/oncotarget.28242
42
Birbal Singh, Francesco Marotta, Gorakh Mal, Rinku Sharma, Devi Gopinath, Gauri Jairath, Ajayta Rialch. Microbiome and Diet Interplay: An Emerging Frontier in PDAC Diagnosis and Prevention. Cancers 2026; 18(8) doi: 10.3390/cancers18081292
43
Elen Deng, Manvita Mareboina, Ilias Georgakopoulos-Soares, Nelson S. Yee. Factors Associated with Stage at Diagnosis in Pancreatic Cancer: Implications for Precision Screening and Early Detection. Biomedicines 2026; 14(5) doi: 10.3390/biomedicines14050992
44
William Bruno, Virginia Andreotti, Alessandra Bisio, Lorenza Pastorino, Giuseppe Fornarini, Stefania Sciallero, Giovanna Bianchi-Scarrà, Alberto Inga, Paola Ghiorzo, Alvaro Galli. Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development. PLOS ONE 2017; 12(12) doi: 10.1371/journal.pone.0189123
45
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand, Pascal Hammel. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacology & Therapeutics 2015; 155 doi: 10.1016/j.pharmthera.2015.08.006
46
Eleonora Lai, Pina Ziranu, Dario Spanu, Marco Dubois, Andrea Pretta, Simona Tolu, Silvia Camera, Nicole Liscia, Stefano Mariani, Mara Persano, Marco Migliari, Clelia Donisi, Laura Demurtas, Valeria Pusceddu, Marco Puzzoni, Mario Scartozzi. BRCA-mutant pancreatic ductal adenocarcinoma. British Journal of Cancer 2021; 125(10) doi: 10.1038/s41416-021-01469-9
47
Yunlin Luo, Mingcheng Nie, Yuekang Chen, Xinyu Huang, Xuehai Cui, Wan Lin, Liyan Xu, Enmin Li, Yinwei Cheng. Clinical Application of PARP1 Inhibitors and Challenges in Cancer Therapy. Current Cancer Drug Targets 2026; 26(1) doi: 10.2174/0115680096327635241021115944
48
Diana Behrens, Ulrike Pfohl, Theresia Conrad, Michael Becker, Bernadette Brzezicha, Britta Büttner, Silvia Wagner, Cora Hallas, Rita Lawlor, Vladimir Khazak, Michael Linnebacher, Thomas Wartmann, Iduna Fichtner, Jens Hoffmann, Mathias Dahlmann, Wolfgang Walther. Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing. Cancers 2023; 15(24) doi: 10.3390/cancers15245753
49
. 2021;  doi: 10.70675/d567c6b8z5273z4d8czba2fz1b589b04e9fe
50
Benjamin Musher, Huili Zhu. Pancreatic Cancer. 2023;  doi: 10.1007/978-3-031-38623-7_4
51
. 2023;  doi: 10.70675/7f463b13zcbf1z4364z9018z305197ecda6e
52
Humaira Sarfraz, Aditi Saha, Khushali Jhaveri, Dae Won Kim. Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma. Current Oncology 2023; 30(6) doi: 10.3390/curroncol30060404
53
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023;  doi: 10.1007/978-981-99-0815-8_48
54
Lisa Lellouche, Lola-Jade Palmieri, Solène Dermine, Catherine Brezault, Stanislas Chaussade, Romain Coriat. Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives. Therapeutic Advances in Medical Oncology 2021; 13 doi: 10.1177/17588359211018539
55
Chenyan Zhang, Pei Zhang, Ke Cheng, Dan Cao. Continuous response to maintenance fuzuloparib for germline BRCA2- mutated metastatic pancreatic adenocarcinoma: a case report and literature review. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1656670
56
Mei Zhan, Hanrui Zheng, Yu Yang, Zhiyao He, Ting Xu, Qiu Li. <p>Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO Trial</p>. Cancer Management and Research 2020;  doi: 10.2147/CMAR.S283169
57
Daniele Fanale, Giorgio Madonia, Antonio Galvano, Marc Peeters, Albert J. ten Tije, Juan Lucio Iovanna, Antonio Russo. Practical Medical Oncology Textbook. UNIPA Springer Series 2021;  doi: 10.1007/978-3-030-56051-5_40
58
Wen‐Ling Kuo, Po‐Han Lin, Meng‐Ting Peng, Chia‐Hui Chu, Chia‐Wei Cho. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single‐country, multi‐center, patient‐reported outcome study. Journal of Genetic Counseling 2023; 32(4) doi: 10.1002/jgc4.1688
59
M. Borecka, P. Zemankova, M. Vocka, P. Soucek, J. Soukupova, P. Kleiblova, J. Sevcik, Z. Kleibl, M. Janatova. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Cancer Genetics 2016; 209(5) doi: 10.1016/j.cancergen.2016.03.003
60
Baohuan Li, Chuanzhen Zhang, Jingjing Wang, Meijuan Zhang, Changhong Liu, Ziping Chen. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients. Molecular Genetics & Genomic Medicine 2020; 8(6) doi: 10.1002/mgg3.1226
61
Shria Kumar, Monica Saumoy, Aaron Oh, Yecheskel Schneider, Randall E. Brand, Amitabh Chak, Gregory G. Ginsberg, Michael L. Kochman, Marcia Irene Canto, Michael Gilbert Goggins, Chin Hur, Fay Kastrinos, Bryson W. Katona, Anil K. Rustgi. Threshold Analysis of the Cost-effectiveness of Endoscopic Ultrasound in Patients at High Risk for Pancreatic Ductal Adenocarcinoma. Pancreas 2021; 50(6) doi: 10.1097/MPA.0000000000001835
62
Shiao Li Oei, Friedemann Schad. Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?. Cancers 2023; 15(4) doi: 10.3390/cancers15041116
63
Carmelo Laface, Riccardo Memeo. Clinical Updates for Gastrointestinal Malignancies. Journal of Personalized Medicine 2023; 13(9) doi: 10.3390/jpm13091424
64
Gina Gheorghe, Simona Bungau, Madalina Ilie, Tapan Behl, Cosmin Mihai Vesa, Ciprian Brisc, Nicolae Bacalbasa, Vladiana Turi, Raluca Simona Costache, Camelia Cristina Diaconu. Early Diagnosis of Pancreatic Cancer: The Key for Survival. Diagnostics 2020; 10(11) doi: 10.3390/diagnostics10110869
65
Sriram Anbil, Kim A. Reiss. Targeting BRCA and PALB2 in Pancreatic Cancer. Current Treatment Options in Oncology 2024; 25(3) doi: 10.1007/s11864-023-01174-0
66
Deqiang Wang, Ruting Guan, Qing Tao, Sisi Liu, Man Yu, Xiaoqin Li. A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-020-00850-6
67
Atul Batra, Patricia A. Tang, Winson Y. Cheung. Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. American Journal of Clinical Oncology 2021; 44(10) doi: 10.1097/COC.0000000000000856
68
Leticia Estefania Campoverde, Felipe Batalini, Yarab Bulushi, Andrea Bullock. Response in BRCA1 mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX. BMJ Case Reports 2022; 15(4) doi: 10.1136/bcr-2022-249370
69
Daniele Campa, Manuela Pastore, Manuel Gentiluomo, Renata Talar-Wojnarowska, Juozas Kupcinskas, Ewa Malecka-Panas, John P. Neoptolemos, Willem Niesen, Pavel Vodicka, Gianfranco Delle Fave, H. Bas Bueno-de-Mesquita, Maria Gazouli, Paola Pacetti, Milena Di Leo, Hidemi Ito, Harald Klüter, Pavel Soucek, Vincenzo Corbo, Kenji Yamao, Satoyo Hosono, Rudolf Kaaks, Yogesh Vashist, Domenica Gioffreda, Oliver Strobel, Yasuhiro Shimizu, Frederike Dijk, Angelo Andriulli, Audrius Ivanauskas, Peter Bugert, Francesca Tavano, Ludmila Vodickova, Carlo Federico Zambon, Martin Lovecek, Stefano Landi, Timothy J. Key, Ugo Boggi, Raffaele Pezzilli, Krzysztof Jamroziak, Beatrice Mohelnikova-Duchonova, Andrea Mambrini, Franco Bambi, Olivier Busch, Valerio Pazienza, Roberto Valente, George E. Theodoropoulos, Thilo Hackert, Gabriele Capurso, Giulia Martina Cavestro, Claudio Pasquali, Daniela Basso, Cosimo Sperti, Keitaro Matsuo, Markus Büchler, Kay-Tee Khaw, Jakob Izbicki, Eithne Costello, Verena Katzke, Christoph Michalski, Anna Stepien, Cosmeri Rizzato, Federico Canzian. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget 2016; 7(35) doi: 10.18632/oncotarget.10935
70
Nora B. Henrikson, Erin J. Aiello Bowles, Paula R. Blasi, Caitlin C. Morrison, Matt Nguyen, Venu G. Pillarisetty, Jennifer S. Lin. Screening for Pancreatic Cancer. JAMA 2019; 322(5) doi: 10.1001/jama.2019.6190
71
Thao N. D. Pham, Mario A. Shields, Christina Spaulding, Daniel R. Principe, Bo Li, Patrick W. Underwood, Jose G. Trevino, David J. Bentrem, Hidayatullah G. Munshi. Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. Cancers 2021; 13(3) doi: 10.3390/cancers13030440
72
Sana Raoof, Anuraag R. Kansal, Ali Tafazzoli, Weicheng Ye, Walter Morris, Denise Zou, A. Mark Fendrick. Impact of Population Cancer Risk on the Cost-effectiveness of Multicancer Early Detection Testing in the United States. Cancer Epidemiology, Biomarkers & Prevention 2025; 34(11) doi: 10.1158/1055-9965.EPI-25-0610
73
Pauline Jeanpierre, Amal Bernoussi, Youcef Mammeri, Vanessa Laguette. Comportements de santé et qualité de vie dans l’après-cancer. Pratiques Psychologiques 2026; 32(2) doi: 10.1016/j.prps.2025.04.001
74
Caroline Goehringer, Christian Sutter, Matthias Kloor, Johannes Gebert, Emily P. Slater, Monika Keller, Irmgard Treiber, Petra Ganschow, Martina Kadmon, Ute Moog. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor. Familial Cancer 2017; 16(2) doi: 10.1007/s10689-016-9952-y
75
Saadeddine Khayat, Karan Choudhary, Jean Claude Nshimiyimana, Jaiprakash Gurav, Asmaa Hneini, Abubakar Nazir, Hassan Chaito, Magda Wojtara, Olivier Uwishema. Pancreatic cancer: from early detection to personalized treatment approaches. Annals of Medicine & Surgery 2024; 86(5) doi: 10.1097/MS9.0000000000002011
76
Bruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, Virginia Andreotti, Federica Grillo, Luca Mastracci, Francesco Spagnolo, Alberto Ballestrero, Paola Queirolo, William Bruno, Paola Ghiorzo. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients. Journal of the American Academy of Dermatology 2019; 80(5) doi: 10.1016/j.jaad.2018.07.060
77
Hedy L. Kindler, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh, Anke Reinacher-Schick, Giampaolo Tortora, Hana Algül, Eileen M. O'Reilly, Sonal Bordia, David McGuinness, Karen Cui, Gershon Y. Locker, Talia Golan. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Journal of Clinical Oncology 2022; 40(34) doi: 10.1200/JCO.21.01604
78
Katie L. Hwang, Wolfram Goessling. Cancer and Zebrafish. Advances in Experimental Medicine and Biology 2016; 916 doi: 10.1007/978-3-319-30654-4_17
79
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini. Prognostic and predictive factors in pancreatic cancer. Oncotarget 2020; 11(10) doi: 10.18632/oncotarget.27518
80
Bruna Dalmasso, Alberto Puccini, Fabio Catalano, Roberto Borea, Maria Laura Iaia, William Bruno, Giuseppe Fornarini, Stefania Sciallero, Sara Elena Rebuzzi, Paola Ghiorzo. Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. International Journal of Molecular Sciences 2022; 23(9) doi: 10.3390/ijms23094709
81
Rana Muhammad Anss Bin Qadir, Musab Bin Umair, Umar Bin Tariq, Arslan Ahmad, Wajeeha Kiran, M Hasaan Shahid. Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends. Cureus 2024;  doi: 10.7759/cureus.72816
82
Barbara Geerinckx, Laure-Anne Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Price. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy. Expert Review of Anticancer Therapy 2023; 23(12) doi: 10.1080/14737140.2023.2270161
83
Jian-Xiong Hu, Cheng-Fei Zhao, Wen-Biao Chen, Qi-Cai Liu, Qu-Wen Li, Yan-Ya Lin, Feng Gao. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World Journal of Gastroenterology 2021; 27(27): 4298-4321 doi: 10.3748/wjg.v27.i27.4298
84
. 2024;  doi: 10.70675/2d1f2e5azea41z4ce5z8bd8z556728461640
85
Gianluca Cassese, Ho-Seong Han, Yoo-Seok Yoon, Jun Suh Lee, Boram Lee, Antonio Cubisino, Fabrizio Panaro, Roberto Ivan Troisi. Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. World Journal of Gastrointestinal Oncology 2023; 15(6): 911-924 doi: 10.4251/wjgo.v15.i6.911
86
Xiaobo Peng, Ling Chen, Yuan Jiao, Yujie Wang, Zhibin Hao, Xianbao Zhan. Application of natural killer cells in pancreatic cancer (Review). Oncology Letters 2021; 22(3) doi: 10.3892/ol.2021.12908
87
Nozomi Okuno, Kazuo Hara. Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling. Journal of Medical Ultrasonics 2024; 51(2) doi: 10.1007/s10396-023-01403-x
88
William Bruno, Giuseppe Fornarini, Paola Ghiorzo. Signs and genetics of rare cancer syndromes with gastroenterological features. World Journal of Gastroenterology 2015; 21(30): 8985-8993 doi: 10.3748/wjg.v21.i30.8985
89
Hanno Matthaei, Alexander Semaan, Ralph H. Hruban. The genetic classification of pancreatic neoplasia. Journal of Gastroenterology 2015; 50(5) doi: 10.1007/s00535-015-1037-4
90
Yunzhen Qian, Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Shengming Deng, He Cheng, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology 2020; 13(1) doi: 10.1186/s13045-020-00958-3
91
Manuel Gentiluomo, Federico Canzian, Andrea Nicolini, Federica Gemignani, Stefano Landi, Daniele Campa. Germline genetic variability in pancreatic cancer risk and prognosis. Seminars in Cancer Biology 2022; 79 doi: 10.1016/j.semcancer.2020.08.003
92
Gian Maria Zaccaria, Nicola Altini, Valentina Mongelli, Francescomaria Marino, Vitoantonio Bevilacqua. Development and validation of a machine learning prognostic model based on an epigenomic signature in patients with pancreatic ductal adenocarcinoma. International Journal of Medical Informatics 2025; 199 doi: 10.1016/j.ijmedinf.2025.105883
93
Anke Kröcher, Gunnar Folprecht, Robert Winzer, Mildred Sergon, Martin Bornhäuser, Jörg Kotzerke, Claudia Brogsitter. Successful Combination of Olaparib and <sup>225</sup>Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation. Case Reports in Oncology 2023; 16(1) doi: 10.1159/000533198
94
Aamir Ali Khan, Xinhui Liu, Xinlong Yan, Muhammad Tahir, Sakhawat Ali, Hua Huang. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression. Cancer and Metastasis Reviews 2021; 40(1) doi: 10.1007/s10555-020-09952-0
95
Anna J. Boland, Anthony A. O’Kane, Richard Buick, Daniel B. Longley, Christopher J. Scott. Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1) doi: 10.1016/j.bbcan.2021.188557
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.